{"id":11212,"date":"2020-10-09T00:00:00","date_gmt":"2020-10-09T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/1970\/01\/01\/nirogacestat-en-association-avec-pf-06863135-pour-traiter-les-patients-atteints-dun-myelome-multiple-recidivant-ou-refractaire-en-anglais\/"},"modified":"2025-08-19T08:28:18","modified_gmt":"2025-08-19T13:28:18","slug":"nirogacestat-en-association-avec-pf-06863135-pour-traiter-les-patients-atteints-dun-myelome-multiple-recidivant-ou-refractaire-en-anglais","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2020\/10\/09\/nirogacestat-en-association-avec-pf-06863135-pour-traiter-les-patients-atteints-dun-myelome-multiple-recidivant-ou-refractaire-en-anglais\/","title":{"rendered":"NIROGACESTAT EN ASSOCIATION AVEC PF-06863135 POUR TRAITER LES PATIENTS ATTEINTS D\u2019UN MY\u00c9LOME MULTIPLE R\u00c9CIDIVANT OU R\u00c9FRACTAIRE (EN ANGLAIS)"},"content":{"rendered":"<p>SpringWorks Therapeutics, Inc. (Nasdaq&nbsp;: SWTX), une soci\u00e9t\u00e9 biopharmaceutique en phase clinique qui se consacre au d\u00e9veloppement de m\u00e9dicaments susceptibles de changer la vie des patients atteints de maladies rares graves et de cancers, a annonc\u00e9 aujourd\u2019hui avoir conclu un accord de collaboration en mati\u00e8re d\u2019essais cliniques avec Pfizer Inc. (NYSE&nbsp;: PFE) pour \u00e9valuer l\u2019inhibiteur de la gamma-s\u00e9cr\u00e9tase (GSI) exp\u00e9rimental de SpringWorks Therapeutics, le nirogacestat, en association avec l\u2019anticorps bisp\u00e9cifique CD3 de l\u2019antig\u00e8ne de maturation des lymphocytes B (BCMA) de Pfizer, PF-06863135, chez les patients atteints d\u2019un my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire.<\/p>\n<p>Cliquez <a href=\"https:\/\/www.morningstar.com\/news\/globe-newswire\/8062618\/springworks-therapeutics-announces-clinical-collaboration-with-pfizer-inc-to-evaluate-nirogacestat-in-combination-with-pf06863135-in-patients-with-relapsed-or-refractory-multiple-myeloma\" target=\"_blank\" rel=\"noopener\"><strong>ici<\/strong><\/a> pour lire l\u2019article complet.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SpringWorks Therapeutics, Inc. (Nasdaq&nbsp;: SWTX), une soci\u00e9t\u00e9 biopharmaceutique en phase clinique qui se consacre au d\u00e9veloppement de m\u00e9dicaments susceptibles de changer la vie des patients atteints de maladies rares graves et de cancers, a annonc\u00e9 aujourd\u2019hui avoir conclu un accord de collaboration en mati\u00e8re d\u2019essais cliniques avec Pfizer Inc. (NYSE&nbsp;: PFE) pour \u00e9valuer l\u2019inhibiteur de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53,50,58,52],"tags":[],"class_list":["post-11212","post","type-post","status-publish","format-standard","hentry","category-actualites-et-evenement","category-news-events","category-nouvelles-de-myelome-canada","category-whats-new-at-myeloma-canada"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=11212"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11212\/revisions"}],"predecessor-version":[{"id":31308,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11212\/revisions\/31308"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=11212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=11212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=11212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}